22,811 Shares in Masimo Corporation $MASI Acquired by Capricorn Fund Managers Ltd

Capricorn Fund Managers Ltd acquired a new stake in shares of Masimo Corporation (NASDAQ:MASI) in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 22,811 shares of the medical equipment provider’s stock, valued at approximately $4,057,000.

Other hedge funds also recently bought and sold shares of the company. Global Retirement Partners LLC bought a new stake in shares of Masimo during the fourth quarter worth $27,000. Aster Capital Management DIFC Ltd bought a new position in shares of Masimo in the fourth quarter worth about $28,000. Los Angeles Capital Management LLC bought a new position in shares of Masimo in the fourth quarter worth about $31,000. Rothschild Investment LLC grew its holdings in shares of Masimo by 12,950.0% in the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 259 shares during the last quarter. Finally, Torren Management LLC purchased a new position in Masimo in the 4th quarter worth about $35,000. Institutional investors own 85.96% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on MASI shares. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Finally, Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. Nine equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $180.40.

Masimo Price Performance

Shares of MASI stock opened at $179.95 on Wednesday. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $179.99. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The stock has a fifty day simple moving average of $179.06 and a two-hundred day simple moving average of $163.86. The stock has a market capitalization of $9.42 billion, a price-to-earnings ratio of -17.07, a P/E/G ratio of 1.82 and a beta of 1.11.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.